FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2177966745> ?p ?o ?g. }

• W2177966745 endingPage "36" @default.
• W2177966745 startingPage "31" @default.
• W2177966745 abstract "Combination immunotherapy with nivolumab and ipilimumab has a high initial response rate in advanced melanoma; however, up to 55% of patients later progress. The efficacy and safety of ipilimumab re-induction in the setting of acquired resistance (AR) to combination immunotherapy is unknown.Patients with advanced melanoma who initially achieved a complete response, partial response or sustained stable disease to induction combination immunotherapy then progressed and were reinduced with ipilimumab (alone or in combination with anti–PD-1) and were analysed retrospectively. Demographics, disease characteristics, efficacy and toxicity were examined.Forty-seven patients were identified from 12 centres. The response rate to reinduction therapy was 12/47 (26%), and disease control rate was 21/47 (45%). Responses appeared more frequent in patients who developed AR after ceasing induction immunotherapy (30% vs. 18%, P = 0.655). Time to AR was 11 months (95% confidence interval [CI], 8–15 months). After a median follow-up of 16 months (95% CI, 10–25 months), responders to reinduction had a median progression-free survival of 14 months (95% CI, 13, NR months), and in the whole cohort, the median overall survival from reinduction was 17 months (95% CI, 12–NR months). Twenty-seven (58%) immune-related adverse events (irAEs) were reported; 18 (38%) were grade 3/4, and in 11 of 27 (40%), the same irAE observed during induction therapy recurred.Reinduction with ipilimumab ± anti–PD-1 has modest clinical activity. Clinicians should be attentive to the risk of irAEs, including recurrence of irAEs that occurred during induction therapy. Future studies are necessary to determine best management after resistance to combination immunotherapy." @default.
• W2177966745 created "2016-06-24" @default.
• W2177966745 creator A5014376121 @default.
• W2177966745 date "2005-09-01" @default.
• W2177966745 modified "2023-10-17" @default.
• W2177966745 title "Traitements systémiques des lymphomes cutanés T épidermotropes (hors interféron et photophérèse)" @default.
• W2177966745 cites W113853239 @default.
• W2177966745 cites W1506762754 @default.
• W2177966745 cites W1606079760 @default.
• W2177966745 cites W169200567 @default.
• W2177966745 cites W1749229087 @default.
• W2177966745 cites W1888421659 @default.
• W2177966745 cites W1906398149 @default.
• W2177966745 cites W1980469090 @default.
• W2177966745 cites W1982953924 @default.
• W2177966745 cites W1988679162 @default.
• W2177966745 cites W1989594290 @default.
• W2177966745 cites W1989716470 @default.
• W2177966745 cites W1991858554 @default.
• W2177966745 cites W1995280636 @default.
• W2177966745 cites W1997916653 @default.
• W2177966745 cites W1999585694 @default.
• W2177966745 cites W2002354934 @default.
• W2177966745 cites W2015404822 @default.
• W2177966745 cites W2016299336 @default.
• W2177966745 cites W2020904611 @default.
• W2177966745 cites W2023392634 @default.
• W2177966745 cites W2028950818 @default.
• W2177966745 cites W2030675083 @default.
• W2177966745 cites W2032243824 @default.
• W2177966745 cites W2037438068 @default.
• W2177966745 cites W2037904834 @default.
• W2177966745 cites W2040281943 @default.
• W2177966745 cites W2042019638 @default.
• W2177966745 cites W2042533565 @default.
• W2177966745 cites W2045733649 @default.
• W2177966745 cites W2058004526 @default.
• W2177966745 cites W2059123617 @default.
• W2177966745 cites W2063735951 @default.
• W2177966745 cites W2067347766 @default.
• W2177966745 cites W2068816082 @default.
• W2177966745 cites W2071000355 @default.
• W2177966745 cites W2072693644 @default.
• W2177966745 cites W2079844206 @default.
• W2177966745 cites W2087742242 @default.
• W2177966745 cites W2090200709 @default.
• W2177966745 cites W2106022925 @default.
• W2177966745 cites W2108503711 @default.
• W2177966745 cites W2112906780 @default.
• W2177966745 cites W2113798657 @default.
• W2177966745 cites W2115782311 @default.
• W2177966745 cites W2126990974 @default.
• W2177966745 cites W2131639604 @default.
• W2177966745 cites W2135087888 @default.
• W2177966745 cites W2137775865 @default.
• W2177966745 cites W2153333333 @default.
• W2177966745 cites W2154495833 @default.
• W2177966745 cites W2154603047 @default.
• W2177966745 cites W2167942239 @default.
• W2177966745 cites W2244683952 @default.
• W2177966745 cites W2345177486 @default.
• W2177966745 cites W2397502967 @default.
• W2177966745 cites W2397714772 @default.
• W2177966745 cites W2401977930 @default.
• W2177966745 cites W2405280516 @default.
• W2177966745 cites W2405367093 @default.
• W2177966745 cites W2406156821 @default.
• W2177966745 cites W2412968332 @default.
• W2177966745 cites W2413754014 @default.
• W2177966745 cites W2416172744 @default.
• W2177966745 cites W2416690108 @default.
• W2177966745 cites W2430020431 @default.
• W2177966745 cites W281042688 @default.
• W2177966745 cites W47357987 @default.
• W2177966745 cites W49417890 @default.
• W2177966745 cites W931775854 @default.
• W2177966745 doi "https://doi.org/10.1016/s0151-9638(05)79617-4" @default.
• W2177966745 hasPublicationYear "2005" @default.
• W2177966745 type Work @default.
• W2177966745 sameAs 2177966745 @default.
• W2177966745 citedByCount "0" @default.
• W2177966745 crossrefType "journal-article" @default.
• W2177966745 hasAuthorship W2177966745A5014376121 @default.
• W2177966745 hasConcept C121608353 @default.
• W2177966745 hasConcept C126322002 @default.
• W2177966745 hasConcept C141071460 @default.
• W2177966745 hasConcept C143998085 @default.
• W2177966745 hasConcept C197934379 @default.
• W2177966745 hasConcept C2777701055 @default.
• W2177966745 hasConcept C2780030458 @default.
• W2177966745 hasConcept C2781433595 @default.
• W2177966745 hasConcept C71924100 @default.
• W2177966745 hasConcept C90924648 @default.
• W2177966745 hasConceptScore W2177966745C121608353 @default.
• W2177966745 hasConceptScore W2177966745C126322002 @default.
• W2177966745 hasConceptScore W2177966745C141071460 @default.
• W2177966745 hasConceptScore W2177966745C143998085 @default.
• W2177966745 hasConceptScore W2177966745C197934379 @default.

• next